Pharmaceutical Companies in Japan

#	Company	Revenue	YoY	Margin	Avg salary	Starting pay	Employees	Shares 1Y
1	Nxera4565	¥29.6B	+2.7%	-28.6%	¥12.6M	-	50	+60.7%
2	Chugai4519	¥1.3T	+7.5%	47.6%	¥12.1M	¥300,000	5,026	−3.2%
3	Peptide Dream4587	¥18.5B	−60.3%	-27.1%	¥11.7M	-	157	−28.4%
4	Eisai4523	¥825.4B	+4.6%	5.3%	¥11.2M	¥350,000	2,979	+10.5%
5	Takeda4502	¥4.5T	−1.7%	9.1%	¥11.0M	¥300,000	4,808	+60.1%
6	Daiichi Sankyo4568	¥2.1T	+12.6%	10.8%	¥11.0M	¥360,500	8,009	−24.9%
7	Otsuka4578	¥2.5T	+6.0%	19.4%	¥10.6M	-	183	+43.5%
8	Astellas4503	¥2.1T	+11.9%	17.9%	¥10.5M	¥326,700	4,105	+59.3%
9	Ono4528	¥515.8B	+5.9%	17.9%	¥10.2M	¥273,000	3,464	+20.2%
10	Shionogi4507	¥499.7B	+14.0%	33.4%	¥10.0M	¥250,000	2,129	+16.7%
11	Kyowa Kirin4151	¥496.8B	+0.3%	-	¥9.94M	¥265,000	4,013	+3.4%
12	Sawai4887	¥201.7B	+6.7%	7.9%	¥9.38M	-	110	−9.4%
13	Nippon Shinyaku4516	¥170.8B	+6.6%	20.8%	¥9.19M	¥279,000	1,876	+6.7%
14	Tsumura4540	¥192.6B	+6.4%	18.3%	¥9.11M	¥277,230	2,858	+6.9%
15	Sumitomo Pharma4506	¥453.3B	+13.7%	23.7%	¥9.06M	¥245,000	1,747	+11.9%
16	Santen4536	¥291.6B	−2.8%	16.4%	¥9.02M	¥314,100	1,884	+18.6%
17	Kaken4521	¥76.9B	−18.3%	-1.2%	¥8.75M	¥268,100	1,086	+4.5%
18	Rohto4527	¥343.7B	+11.4%	12.0%	¥8.26M	¥240,000	1,753	+14.7%
19	JCR4552	¥40.3B	+21.9%	1.4%	¥8.19M	¥230,000	937	−9.0%
20	Zeria4559	¥89.2B	+2.1%	13.9%	¥7.99M	¥288,060	872	−1.2%
21	Kissei4547	¥97.4B	+10.3%	-3.0%	¥7.98M	¥280,000	1,297	−5.5%
22	Kobayashi4967	¥165.7B	+0.1%	9.0%	¥7.57M	¥243,760	1,665	+38.3%
23	Suzuken9987	¥2.5T	+3.6%	1.5%	¥7.45M	¥300,000	2,991	+2.3%
24	Towa4553	¥273.7B	+5.4%	8.4%	¥6.95M	¥240,000	2,899	+24.2%

Revenue, operating margin and YoY are from the latest full-year consolidated results. Average salary, starting salary (monthly) and employees are for the reporting entity per its annual securities report; for pure holding companies with fewer than 50 staff the average salary is shown as "-" because it isn't representative. Shares 1Y is a closing-price reference (vs. about a year earlier).